Floden, Lysbeth http://orcid.org/0000-0003-0584-6227
Hudgens, Stacie
Jamieson, Carol
Popova, Vanina
Drevets, Wayne C.
Cooper, Kimberly
Singh, Jaskaran
Clinical trials referenced in this document:
Documents that mention this clinical trial
Evaluation of Individual Items of the Patient Health Questionnaire (PHQ-9) and Montgomery-Asberg Depression Rating Scale (MADRS) in Adults with Treatment-Resistant Depression Treated with Esketamine Nasal Spray Combined with a New Oral Antidepressant
https://doi.org/10.1007/s40263-022-00916-2
Population Pharmacokinetics of Esketamine Nasal Spray and its Metabolite Noresketamine in Healthy Subjects and Patients with Treatment-Resistant Depression
https://doi.org/10.1007/s40262-020-00953-4
Funding for this research was provided by:
janssen pharmaceuticals (JN1024)
Article History
Accepted: 14 March 2022
First Online: 20 April 2022
Declarations
:
: This study and its publication was sponsored by Janssen Pharmaceutical Companies of Johnson & Johnson.
: CJ, VP, WD, KC, and JS are employees of Janssen Pharmaceutical Companies of Johnson & Johnson. LF and SH declare no competing interests.
: The datasets generated and/or analyzed during the current study are not publicly available, but are available from the corresponding author on reasonable request.
: All authors contributed to the conception and design, analysis, interpretation, manuscript revisions, approval of the final version to be published, and agree to be accountable for all aspects of the work.
: All study procedures were in accordance with ethical standards of the 1964 Helsinki Declaration and its later amendments, relevant laws, institutional guidelines, and approved by an institutional review board.
: All participants provided informed consent.
: Not applicable.
: Not applicable.